General Information
Version
4.0
Revision date
2019-09-19
Product name
RohmFloc
1.2.1 Relevant identified uses
Industrial distribution Industrial USE as reactive agent/processing aid and for general chemical applications
Emergency telephone
+47 22 59 13 00, +47 21 03 44 52
Icons in SDS
Company Information
company name
Yara Norge AS
e-mail address of the competent person responsible for the Safety Data Sheet
yara-kjemikalieordre@yara.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H314, H318
Hazard statements
Code
Statements
H314
Causes severe skin burns and eye damage
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Danger
Hazard statements
H314 Causes severe skin burns and eye damage.
Prevention
P260-b Do not breathe gas or vapour. P280-d Wear protective gloves/clothing and eye/face protection.
Response
P305 IF IN EYES: P351 Rinse cautiously with water for several minutes. P338 Remove contact lenses, if present and easy to do. Continue rinsing. P310 Immediately call a POISON CENTER or doctor/physician. P304 IF INHALED: P340 Remove person to fresh air and keep comfortable for breathing. P303 IF ON SKIN (or hair): P361-a Take off immediately all contaminated clothing. P353 Rinse skin with water.
Hazardous Ingredients
Dithiocarbamin-derivates reactionproducts, Sodium-salts EU Regulation (EC) No. One or more of the following entries are applicable; 3, 58
Special packaging requirements
Containers to be fitted with Not applicable. child-resistant fastenings
Tactile warning of danger
Not applicable.
Other hazards which do not result in classification
None.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Classification : Skin Corr. 1, H314 Eye Dam. 1, H318 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
